Resources: Doctor Match | Mesothelioma Clinical Trials | Blog
Call Us for More Information
800.615.2270
Alabama (AL)
Arizona (AZ)
California (CA)
Colorado (CO)
Connecticut (CT)
Delaware (DE)
Washington D.C. (DC)
Florida (FL)
Georgia (GA)
Hawaii (HI)
Illinois (IL)
Indiana (IN)
Maryland (MD)
Massachusetts (MA)
Michigan (MI)
Minnesota (MN)
Missouri (MO)
Nebraska (NE)
Nevada (NV)
New Jersey (NJ)
New York (NY)
North Carolina (NC)
Ohio (OH)
Oregon (OR)
Pennsylvania (PA)
South Carolina (SC)
Tennessee (TN)
Texas (TX)
Vermont (VT)
Washington (WA)
Wisconsin (WI)
National (U.S.)
Dr. Brian W. Loggie

Dr. Brian W. Loggie

Creighton University School of Medicine

doctor match
601 North 30th Street, Suite 2803, Omaha, NE 68131
402-280-4100
Title
Chief, Division of Surgical Oncology
Specialty
Surgical Oncology
Education
McGill Unversity
Residency
Surgery - Montreal General Hospital
Fast Fact
Before Loggie joined the team at Creighton University School of Medicine, the hospital had no Division of Surgical Oncology - Loggie founded the program in 2002.

Bio

Brian Loggie, M.D., ventured into uncharted waters when in the 1990s he pioneered a mesothelioma treatment often referred to as heated intraperitoneal chemotherapy, or heated chemotherapy.

It was early in Loggie's medical career that he helped develop the new cancer treatment that combined surgery with the application of heated chemotherapy drugs. The benefits were immediate. The heat made the drugs more effective in killing the various kinds of cancer. As a result, the procedure is now widely used.

Almost 20 years later, he was taking chances again - and seeing immediate results.

Loggie, professor of surgery and director of the Cancer Biology Program at Creighton University Medical Center in Omaha, Nebraska, led a team of doctors and nurses to the country of Haiti immediately following the devastating earthquake of 2010.

The team was in Haiti for 11 days, working 14-hour shifts of trauma surgery under harsh, often deplorable conditions. They repaired orthopedic injuries, treated open and infected fractures, and amputated limbs, all to save lives.

Loggie returned with a new enthusiasm for his practice, treating and studying peritoneal carcinomatosis and peritoneal mesothelioma.

Loggie has authored or co-authored many articles and papers detailing treatments he has developed, many detailing the research of peritoneal mesothelioma.

Peritoneal mesothelioma is a rare form of the disease, representing just 20 percent of all mesothelioma cases. It develops in the lining of the abdominal cavity and is directly related to the inhalation or ingestion of asbestos.

Loggie earned his medical degree from McGill University, in Montreal, Canada. His post-graduate training included an internship with the Department of Surgery at Montreal General Hospital in Montreal, where he later did his residency.

mesothelioma-packet
Name:
Address:
City, State, Zip:
Country:
Phone Number:
Email:
Diagnosis:
Comments:
terms of use